Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 380.20
+5.20 (1.39%)
Jan 28, 2026, 3:10 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 143.46 billion as of January 28, 2026. Its market cap has decreased by -48.44% in one year.
Market Cap
143.46B
Enterprise Value
145.33B
Revenue
12.11B
Ranking
n/a
PE Ratio
54.51
Stock Price
380.20
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 143.46B, an increase of 425,542.12%. That is a compound annual growth rate of 313.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 143.46B | -29.06% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 290.20B |
| Gland Pharma | 277.20B |
| Wockhardt | 219.62B |
| Piramal Pharma | 201.05B |
| Eris Lifesciences | 191.94B |
| Alembic Pharmaceuticals | 150.28B |
| NATCO Pharma | 149.01B |
| Alivus Life Sciences | 108.44B |